1
|
Attig L, Vigé A, Gabory A, Karimi M, Beauger A, Gross MS, Athias A, Gallou-Kabani C, Gambert P, Ekstrom TJ, Jais JP, Junien C. Dietary alleviation of maternal obesity and diabetes: increased resistance to diet-induced obesity transcriptional and epigenetic signatures. PLoS One 2013; 8:e66816. [PMID: 23826145 PMCID: PMC3691260 DOI: 10.1371/journal.pone.0066816] [Citation(s) in RCA: 40] [Impact Index Per Article: 3.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/01/2012] [Accepted: 05/15/2013] [Indexed: 02/07/2023] Open
Abstract
According to the developmental origins of health and diseases (DOHaD), and in line with the findings of many studies, obesity during pregnancy is clearly a threat to the health and well-being of the offspring, later in adulthood. We previously showed that 20% of male and female inbred mice can cope with the obesogenic effects of a high-fat diet (HFD) for 20 weeks after weaning, remaining lean. However the feeding of a control diet (CD) to DIO mice during the periconceptional/gestation/lactation period led to a pronounced sex-specific shift (17% to 43%) from susceptibility to resistance to HFD, in the female offspring only. Our aim in this study was to determine how, in the context of maternal obesity and T2D, a CD could increase resistance on female fetuses. Transcriptional analyses were carried out with a custom-built mouse liver microarray and by quantitative RT-PCR for muscle and adipose tissue. Both global DNA methylation and levels of pertinent histone marks were assessed by LUMA and western blotting, and the expression of 15 relevant genes encoding chromatin-modifying enzymes was analyzed in tissues presenting global epigenetic changes. Resistance was associated with an enhancement of hepatic pathways protecting against steatosis, the unexpected upregulation of neurotransmission-related genes and the modulation of a vast imprinted gene network. Adipose tissue displayed a pronounced dysregulation of gene expression, with an upregulation of genes involved in lipid storage and adipocyte hypertrophy or hyperplasia in obese mice born to lean and obese mothers, respectively. Global DNA methylation, several histone marks and key epigenetic regulators were also altered. Whether they were themselves lean (resistant) or obese (sensitive), the offspring of lean and obese mice clearly differed in terms of several metabolic features and epigenetic marks suggesting that the effects of a HFD depend on the leanness or obesity of the mother.
Collapse
Affiliation(s)
- Linda Attig
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- INSERM U781 AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants, Paris, France
| | - Alexandre Vigé
- INSERM U781 AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants, Paris, France
| | - Anne Gabory
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- INSERM U781 AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants, Paris, France
| | - Moshen Karimi
- Laboratory for Medical Epigenetics, Center for Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | - Aurore Beauger
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- INSERM U781 AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants, Paris, France
| | - Marie-Sylvie Gross
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- INSERM U781 AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants, Paris, France
| | - Anne Athias
- IFR100 Santé-STIC, Plateau Technique Lipidomique, CHU Bocage Bat B2, Dijon, France
| | - Catherine Gallou-Kabani
- INSERM U781 AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants, Paris, France
| | - Philippe Gambert
- IFR100 Santé-STIC, Laboratoire de Biochimie Médicale, Plateau Technique de Biologie, Dijon, France
| | - Tomas J. Ekstrom
- Laboratory for Medical Epigenetics, Center for Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
| | - Jean-Philippe Jais
- Service de Biostatistique et Informatique Médicale, Université Paris Descartes, Hôpital Necker-Enfants Malades, Paris, France
| | - Claudine Junien
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- INSERM U781 AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants, Paris, France
- Laboratory for Medical Epigenetics, Center for Molecular Medicine, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden
- * E-mail:
| |
Collapse
|
2
|
Gabory A, Ferry L, Fajardy I, Jouneau L, Gothié JD, Vigé A, Fleur C, Mayeur S, Gallou-Kabani C, Gross MS, Attig L, Vambergue A, Lesage J, Reusens B, Vieau D, Remacle C, Jais JP, Junien C. Maternal diets trigger sex-specific divergent trajectories of gene expression and epigenetic systems in mouse placenta. PLoS One 2012; 7:e47986. [PMID: 23144842 PMCID: PMC3489896 DOI: 10.1371/journal.pone.0047986] [Citation(s) in RCA: 138] [Impact Index Per Article: 11.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/08/2012] [Accepted: 09/19/2012] [Indexed: 12/20/2022] Open
Abstract
Males and females responses to gestational overnutrition set the stage for subsequent sex-specific differences in adult onset non communicable diseases. Placenta, as a widely recognized programming agent, contibutes to the underlying processes. According to our previous findings, a high-fat diet during gestation triggers sex-specific epigenetic alterations within CpG and throughout the genome, together with the deregulation of clusters of imprinted genes. We further investigated the impact of diet and sex on placental histology, transcriptomic and epigenetic signatures in mice. Both basal gene expression and response to maternal high-fat diet were sexually dimorphic in whole placentas. Numerous genes showed sexually dimorphic expression, but only 11 genes regardless of the diet. In line with the key role of genes belonging to the sex chromosomes, 3 of these genes were Y-specific and 3 were X-specific. Amongst all the genes that were differentially expressed under a high-fat diet, only 16 genes were consistently affected in both males and females. The differences were not only quantitative but remarkably qualitative. The biological functions and networks of genes dysregulated differed markedly between the sexes. Seven genes of the epigenetic machinery were dysregulated, due to effects of diet, sex or both, including the Y- and X-linked histone demethylase paralogues Kdm5c and Kdm5d, which could mark differently male and female epigenomes. The DNA methyltransferase cofactor Dnmt3l gene expression was affected, reminiscent of our previous observation of changes in global DNA methylation. Overall, this striking sexual dimorphism of programming trajectories impose a considerable revision of the current dietary interventions protocols.
Collapse
Affiliation(s)
- Anne Gabory
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- L’Ecole Nationale Vétérinaire d’Alfort (ENVA), Maisons Alfort, France
- Inserm; AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, SBIM, Paris, France
| | - Laure Ferry
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- L’Ecole Nationale Vétérinaire d’Alfort (ENVA), Maisons Alfort, France
| | - Isabelle Fajardy
- EA 4489 Unité Environnement Périnatal et Croissance, Department of Diabetology, Biology and Pathology Center, Huriez Hospital, CHRU Lille, Lille, France
| | - Luc Jouneau
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- L’Ecole Nationale Vétérinaire d’Alfort (ENVA), Maisons Alfort, France
| | - Jean-David Gothié
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- L’Ecole Nationale Vétérinaire d’Alfort (ENVA), Maisons Alfort, France
| | - Alexandre Vigé
- Inserm; AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, SBIM, Paris, France
| | - Cécile Fleur
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- L’Ecole Nationale Vétérinaire d’Alfort (ENVA), Maisons Alfort, France
| | - Sylvain Mayeur
- EA 4489 Unité Environnement Périnatal et Croissance, Université de Lille 1, Bâtiment SN4, Villeneuve d’Ascq, France
| | - Catherine Gallou-Kabani
- Inserm; AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, SBIM, Paris, France
| | - Marie-Sylvie Gross
- Inserm; AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, SBIM, Paris, France
| | - Linda Attig
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- L’Ecole Nationale Vétérinaire d’Alfort (ENVA), Maisons Alfort, France
- Inserm; AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, SBIM, Paris, France
| | - Anne Vambergue
- EA 4489 Unité Environnement Périnatal et Croissance, Department of Diabetology, Biology and Pathology Center, Huriez Hospital, CHRU Lille, Lille, France
| | - Jean Lesage
- EA 4489 Unité Environnement Périnatal et Croissance, Université de Lille 1, Bâtiment SN4, Villeneuve d’Ascq, France
| | - Brigitte Reusens
- Laboratory of Cell Biology, Institute of Life Sciences, Université catholique de Louvain, Louvain-la-Neuve, Belgium
| | - Didier Vieau
- EA 4489 Unité Environnement Périnatal et Croissance, Université de Lille 1, Bâtiment SN4, Villeneuve d’Ascq, France
| | - Claude Remacle
- Laboratory of Cell Biology, Institute of Life Sciences, Université catholique de Louvain, Louvain-la-Neuve, Belgium
| | - Jean-Philippe Jais
- Service de Biostatistique et Informatique Médicale, Hôpital Necker-Enfants Malades, Paris, France
| | - Claudine Junien
- INRA, UMR1198 Biologie du Développement et Reproduction, Jouy-en-Josas, France
- L’Ecole Nationale Vétérinaire d’Alfort (ENVA), Maisons Alfort, France
- Inserm; AP-HP; Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, SBIM, Paris, France
- Université de Versailles Saint-Quentin-en-Yvelines, Versailles, France
- * E-mail:
| |
Collapse
|
3
|
Firlej V, Mathieu JRR, Gilbert C, Lemonnier L, Nakhlé J, Gallou-Kabani C, Guarmit B, Morin A, Prevarskaya N, Delongchamps NB, Cabon F. Thrombospondin-1 triggers cell migration and development of advanced prostate tumors. Cancer Res 2011; 71:7649-58. [PMID: 22037878 DOI: 10.1158/0008-5472.can-11-0833] [Citation(s) in RCA: 73] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
The antitumor effects of pharmacologic inhibitors of angiogenesis are hampered in patients by the rapid development of tumor resistance, notably through increased invasiveness and accelerated metastasis. Here, we reevaluated the role of the endogenous antiangiogenic thrombospondin 1 (TSP1) in prostate carcinomas in which angiogenesis is an active process. In xenografted tumors, we observed that TSP1 altogether inhibited angiogenesis and fostered tumor development. Our results show that TSP1 is a potent stimulator of prostate tumor cell migration. This effect required CD36, which also mediates TSP1 antiangiogenic activity, and was mimicked by an antiangiogenic TSP1-derived peptide. As suspected for pharmacologic inhibitors of angiogenesis, the TSP1 capacities to increase hypoxia and to trigger cell migration are thus inherently linked. Importantly, although antiangiogenic TSP1 increases hypoxia in vivo, our data show that, in turn, hypoxia induced TSP1, thus generating a vicious circle in prostate tumors. In radical prostatectomy specimens, we found TSP1 expression significantly associated with invasive tumors and with tumors which eventually recurred. TSP1 may thus help select patients at risk of prostate-specific antigen relapse. Together, the data suggest that intratumor disruption of the hypoxic cycle through TSP1 silencing will limit tumor invasion.
Collapse
|
4
|
Morin A, Fritsch L, Mathieu JRR, Gilbert C, Guarmit B, Firlej V, Gallou-Kabani C, Vieillefond A, Delongchamps NB, Cabon F. Identification of CAD as an androgen receptor interactant and an early marker of prostate tumor recurrence. FASEB J 2011; 26:460-7. [PMID: 21982950 DOI: 10.1096/fj.11-191296] [Citation(s) in RCA: 12] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
Abstract
Markers of prostate tumor recurrence after radical prostatectomy are lacking and highly demanded. The androgen receptor (AR) is a nuclear receptor that plays a pivotal role in normal and cancerous prostate tissue. AR interacts with a number of proteins modulating its stability, localization, and activity. To test the hypothesis that an increased expression of AR partners might foster tumor development, we immunopurified AR partners in human tumors xenografted into mice. One of the identified AR partners was the multifunctional enzyme carbamoyl-phosphate synthetase II, aspartate transcarbamylase, and dihydroorotase (CAD), which catalyzes the 3 initial steps of pyrimidine biosynthesis. We combined experiments in C4-2, LNCaP, 22RV1, and PC3 human prostate cell lines and analysis of frozen radical prostatectomy samples to study the CAD-AR interaction. We show here that in prostate tumor cells, CAD fosters AR translocation into the nucleus and stimulates its transcriptional activity. Notably, in radical prostatectomy specimens, CAD expression was not correlated with proliferation markers, but a higher CAD mRNA level was associated with local tumor extension (P=0.049) and cancer relapse (P=0.017). These results demonstrate an unsuspected function for a key metabolic enzyme and identify CAD as a potential predictive marker of cancer relapse.
Collapse
Affiliation(s)
- Aurélie Morin
- Centre National de la Recherche Scientifique, University of Paris Sud,Villejuif, France
| | | | | | | | | | | | | | | | | | | |
Collapse
|
5
|
Gallou-Kabani C, Gabory A, Tost J, Karimi M, Mayeur S, Lesage J, Boudadi E, Gross MS, Taurelle J, Vigé A, Breton C, Reusens B, Remacle C, Vieau D, Ekström TJ, Jais JP, Junien C. Sex- and diet-specific changes of imprinted gene expression and DNA methylation in mouse placenta under a high-fat diet. PLoS One 2010; 5:e14398. [PMID: 21200436 PMCID: PMC3006175 DOI: 10.1371/journal.pone.0014398] [Citation(s) in RCA: 183] [Impact Index Per Article: 13.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/24/2010] [Accepted: 11/26/2010] [Indexed: 12/12/2022] Open
Abstract
BACKGROUND Changes in imprinted gene dosage in the placenta may compromise the prenatal control of nutritional resources. Indeed monoallelic behaviour and sensitivity to changes in regional epigenetic state render imprinted genes both vulnerable and adaptable. METHODS AND FINDINGS We investigated whether a high-fat diet (HFD) during pregnancy modified the expression of imprinted genes and local and global DNA methylation patterns in the placenta. Pregnant mice were fed a HFD or a control diet (CD) during the first 15 days of gestation. We compared gene expression patterns in total placenta homogenates, for male and female offspring, by the RT-qPCR analysis of 20 imprinted genes. Sexual dimorphism and sensitivity to diet were observed for nine genes from four clusters on chromosomes 6, 7, 12 and 17. As assessed by in situ hybridization, these changes were not due to variation in the proportions of the placental layers. Bisulphite-sequencing analysis of 30 CpGs within the differentially methylated region (DMR) of the chromosome 17 cluster revealed sex- and diet-specific differential methylation of individual CpGs in two conspicuous subregions. Bioinformatic analysis suggested that these differentially methylated CpGs might lie within recognition elements or binding sites for transcription factors or factors involved in chromatin remodelling. Placental global DNA methylation, as assessed by the LUMA technique, was also sexually dimorphic on the CD, with lower methylation levels in male than in female placentae. The HFD led to global DNA hypomethylation only in female placenta. Bisulphite pyrosequencing showed that neither B1 nor LINE repetitive elements could account for these differences in DNA methylation. CONCLUSIONS A HFD during gestation triggers sex-specific epigenetic alterations within CpG and throughout the genome, together with the deregulation of clusters of imprinted genes important in the control of many cellular, metabolic and physiological functions potentially involved in adaptation and/or evolution. These findings highlight the importance of studying both sexes in epidemiological protocols and dietary interventions.
Collapse
Affiliation(s)
- Catherine Gallou-Kabani
- Inserm, AP-HP, Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, Paris, France
| | - Anne Gabory
- Inserm, AP-HP, Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, Paris, France
- INRA, UMR1198, UMR INRA/ENV Maisons-Alfort/CNRS: Biologie du Développement et Reproduction, (ENV Maisons-Alfort; CNRS), Physiologie Animale et Systèmes d'Elevage, Centre de recherche de Jouy-en-Josas, Jouy-en-Josas, France
| | - Jörg Tost
- Laboratoire d'Epigénétique, CEA - Institut de Génomique, Centre National de Génotypage, Evry, France
| | - Mohsen Karimi
- Laboratory for Medical Epigenetics, Department of Clinical Neuroscience, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
| | - Sylvain Mayeur
- Unité Environnement Périnatal et Croissance, EA 4489, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq, France
| | - Jean Lesage
- Unité Environnement Périnatal et Croissance, EA 4489, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq, France
| | - Elsa Boudadi
- Inserm, AP-HP, Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, Paris, France
| | - Marie-Sylvie Gross
- Inserm, AP-HP, Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, Paris, France
| | - Julien Taurelle
- Inserm, AP-HP, Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, Paris, France
| | - Alexandre Vigé
- Inserm, AP-HP, Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, Paris, France
| | - Christophe Breton
- Unité Environnement Périnatal et Croissance, EA 4489, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq, France
| | - Brigitte Reusens
- Laboratory of Cell Biology, Institute of Life Sciences, Catholic University of Louvain, Louvain-la-Neuve, Belgium
| | - Claude Remacle
- Laboratory of Cell Biology, Institute of Life Sciences, Catholic University of Louvain, Louvain-la-Neuve, Belgium
| | - Didier Vieau
- Unité Environnement Périnatal et Croissance, EA 4489, Université des Sciences et Technologies de Lille, Villeneuve d'Ascq, France
| | - Tomas J. Ekström
- Laboratory for Medical Epigenetics, Department of Clinical Neuroscience, Centre for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
| | | | - Claudine Junien
- Inserm, AP-HP, Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, U781, Paris, France
- INRA, UMR1198, UMR INRA/ENV Maisons-Alfort/CNRS: Biologie du Développement et Reproduction, (ENV Maisons-Alfort; CNRS), Physiologie Animale et Systèmes d'Elevage, Centre de recherche de Jouy-en-Josas, Jouy-en-Josas, France
| |
Collapse
|
6
|
Morin A, Gallou-Kabani C, Mathieu J, Cabon F. Systemic Delivery and Quantification of Unformulated Interfering RNAs In Vivo. Curr Top Med Chem 2009; 9:1117-29. [DOI: 10.2174/156802609789630820] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
|
7
|
Abstract
There is accumulating evidence for nongenetic transgenerational inheritance with conspicuous marked sexual dimorphism for both the modes of transmission and the effects. Given the critical spatiotemporal windows, the role of the sex chromosomes, the regulatory pathways underlying sexual differentiation during gonad and brain development, and other developmental processes, as well as the lifelong impact of sex hormones, it is not surprising that most of the common diseases, which often take root in early development, display some degree of sex bias. The flexibility of epigenetic marks may make it possible for environmental and nutritional factors, or endocrine disruptors to alter-during a particular spatiotemporal window in a sex-specific manner-the sex-specific methylation or demethylation of specific CpGs and histone/chromatin modifications underlying sex-specific expression of a substantial proportion of genes. Thus, finely tuned developmental program aspects, specific to one sex, may be more sensitive to specific environmental challenges, particularly during developmental programming and gametogenesis, but also throughout the individual's life under the influence of sex steroid hormones. This review highlights the importance of studying both sexes in epidemiologic protocols or dietary interventions both in humans and in experimental models in animals.
Collapse
Affiliation(s)
- Alexandre Vigé
- Inserm U781 Genetics and Epigenetics of Metabolic Diseases, Neurosensorial Diseases and Development, Hôpital Necker-Enfants Malades, Université Paris Deseartes, Paris, France
| | | | | |
Collapse
|
8
|
Abstract
Epigenetic misprogramming during development is widely thought to have a persistent effect on the health of the offspring and may even be transmitted to the next generation. However, little is known about the stochastically, genetically and environmentally triggered epimutations occurring during an individual's lifetime. They may result from replication-dependent, replication-independent or DNA repair events. The rhythmic, circadian induction of a substantial proportion of genes by a network of clock genes, one of which is a histone acetyl transferase, nuclear receptors and transcription factors is controlled by chromatin remodeling. The associated circadian epigenetic patterns must be transient, sensitive to environmental cues and reversible. Links have been found between circadian rhythms and major components of energy homeostasis, thermogenesis and hunger-satiety, rest-activity rhythms and the sleep-wake cycle. Thus poorly adapted behavior or lifestyle and desynchronized cues may disturb the modulation of gene expression. This functional asynchrony may ultimately lead to persistence of aberrant and unphased "locking"or "leakage" of gene expression and inadapted responses in the body as a whole.
Collapse
Affiliation(s)
- Catherine Gallou-Kabani
- Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, Paris, France
| | | | | |
Collapse
|
9
|
Gallou-Kabani C, Vigé A, Gross MS, Rabès JP, Boileau C, Larue-Achagiotis C, Tomé D, Jais JP, Junien C. C57BL/6J and A/J mice fed a high-fat diet delineate components of metabolic syndrome. Obesity (Silver Spring) 2007; 15:1996-2005. [PMID: 17712117 DOI: 10.1038/oby.2007.238] [Citation(s) in RCA: 172] [Impact Index Per Article: 10.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 02/07/2023]
Abstract
OBJECTIVE The aim of this study was to assess the suitability of A/J and C57BL/6J mice of both sexes as models of some components of the human metabolic syndrome (MetS) under nutritional conditions more comparable with the actual worldwide diet responsible for the increased incidence of the MetS. RESEARCH METHODS We fed large cohorts (n = 515) of two strains of mice, A/J and the C57BL/6J, and of both sexes a high-fat diet (HFD; 60% fat) that, in contrast with most previous reports using saturated fats, was enriched in mono- and polyunsaturated fatty acids, thus more closely mimicking most Western diets, or a control diet (10% fat), for 20 weeks. RESULTS In sharp contrast to previous reports, weight gain and hyperleptinemia were similar in both strains and sexes. Hyperinsulinemia, glucose tolerance, insulin resistance, and hypercholesterolemia were observed, although with important differences between strains and sexes. A/J males displayed severely impaired glucose tolerance and insulin resistance. However, in contrast with C57BL6/J mice, which displayed overt type 2 diabetes, A/J mice of both sexes remained normoglycemic. DISCUSSION With important differences in magnitude and time course, the phenotypic and metabolic characteristics of both strains and both sexes on this HFD demonstrate that these models are very useful for identifying the mechanisms underlying progression or resistance to subsequent type 2 diabetes.
Collapse
Affiliation(s)
- Catherine Gallou-Kabani
- Institut National de la Santé et de la Recherche Médicale, Assistance Publique-Hôpitaux de Paris, Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | | | |
Collapse
|
10
|
Gallou-Kabani C, Vigé A, Gross MS, Junien C. Nutri-epigenomics: lifelong remodelling of our epigenomes by nutritional and metabolic factors and beyond. Clin Chem Lab Med 2007; 45:321-7. [PMID: 17378726 DOI: 10.1515/cclm.2007.081] [Citation(s) in RCA: 59] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/06/2023]
Abstract
The phenotype of an individual is the result of complex interactions between genotype, epigenome and current, past and ancestral environment, leading to lifelong remodelling of our epigenomes. Various replication-dependent and -independent epigenetic mechanisms are involved in developmental programming, lifelong stochastic and environmental deteriorations, circadian deteriorations, and transgenerational effects. Several types of sequences can be targets of a host of environmental factors and can be associated with specific epigenetic signatures and patterns of gene expression. Depending on the nature and intensity of the insult, the critical spatiotemporal windows and developmental or lifelong processes involved, these epigenetic alterations can lead to permanent changes in tissue and organ structure and function, or to reversible changes using appropriate epigenetic tools. Given several encouraging trials, prevention and therapy of age- and lifestyle-related diseases by individualised tailoring of optimal epigenetic diets or drugs are conceivable. However, these interventions will require intense efforts to unravel the complexity of these epigenetic, genetic and environment interactions and to evaluate their potential reversibility with minimal side effects.
Collapse
Affiliation(s)
- Catherine Gallou-Kabani
- 1. Inserm, AP-HP, Université Paris-Descartes, Faculté de Médecine, Hôpital Necker-Enfants Malades, Inserm U781, Paris, France
| | | | | | | |
Collapse
|
11
|
Gallou-Kabani C, Vigé A, Gross MS, Boileau C, Rabes JP, Fruchart-Najib J, Jais JP, Junien C. Resistance to high-fat diet in the female progeny of obese mice fed a control diet during the periconceptual, gestation, and lactation periods. Am J Physiol Endocrinol Metab 2007; 292:E1095-100. [PMID: 17164437 DOI: 10.1152/ajpendo.00390.2006] [Citation(s) in RCA: 54] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
With the worldwide epidemic of metabolic syndrome (MetS), the proportion of women that are overweight/obese and overfed during pregnancy has increased. The resulting abnormal uterine environment may have deleterious effects on fetal metabolic programming and lead to MetS in adulthood. A balanced/restricted diet and/or physical exercise often improve metabolic abnormalities in individuals with obesity and type 2 diabetes mellitus (T2D). We investigated whether reducing fat intake during the periconceptual/gestation/lactation period in mothers with high-fat diet (HFD)-induced obesity could be used to modify fetal/neonatal MetS programming positively, thereby preventing MetS. First generation (F1) C57BL/6J female mice with HFD-induced obesity and T2D were crossed with F1 males on control diet (CD). These F1 females were switched to a CD during the periconceptual/gestation/lactation period. At weaning, both male and female second generation (F2) mice were fed a HFD. Weight, caloric intake, lipid parameters, glucose, and insulin sensitivity were assessed. Sensitivity/resistance to the HFD differed significantly between generations and sexes. A similar proportion of the F1 and F2 males (80%) developed hyperphagia, obesity, and T2D. In contrast, a significantly higher proportion of the F2 females (43%) than of the previous F1 generation (17%) were resistant (P<0.01). Despite having free access to the HFD, these female mice were no longer hyperphagic and remained lean, with normal insulin sensitivity and glycemia but mild hypercholesterolemia and glucose intolerance, thus displaying a "satiety phenotype." This suggests that an appropriate dietary fatty acid profile and intake during the periconceptual/gestation/lactation period helps the female offspring to cope with deleterious intrauterine conditions.
Collapse
Affiliation(s)
- Catherine Gallou-Kabani
- Institut National de la Santé et de la Recherche Médicale, Université Paris-Descartes, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | | | | | | | | |
Collapse
|
12
|
Vigé A, Gallou-Kabani C, Gross MS, Fabre A, Junien C, Jais JP. An oligonucleotide microarray for mouse imprinted genes profiling. Cytogenet Genome Res 2006; 113:253-61. [PMID: 16575188 DOI: 10.1159/000090840] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2005] [Accepted: 11/04/2005] [Indexed: 01/07/2023] Open
Abstract
Genomic imprinting is an epigenetic phenomenon unique to mammals that causes some genes to be expressed according to their parental origin. It results in developmental asymmetry in the function of the parental genomes. We describe here a method for the profiling of imprinted genes based on the development of a mouse imprinting microchip containing oligonucleotides corresponding to 493 genes, including most of the known imprinted genes (IG = 63), genes involved in epigenetic processes (EPI = 15), in metabolism (= 147), in obesity (= 10) and in neurotransmission (= 256) and housekeeping reference genes (= 2). This custom oligonucleotide microarray has been constructed to make data analysis and handling more manageable than pangenomic microarrays. As a proof of concept we present the differential expression of these 493 genes in different tissues (liver, placenta, embryo) of C57BL6/J mice fed different diets. Appropriate experimental strategies and statistical tools were defined at each step of the data analysis process with regard to the different sources of constraints. Data were confirmed by expression analyses based on quantitative real-time PCR. These oligochips should make it possible to increase our understanding of the involvement of imprinted genes in the timing of expression programs, tissue by tissue, stage by stage, in response to nutrients, lifestyles and other as yet unknown critical environmental factors in a variety of physiopathological situations, and in animals of different strains, ages and sexes. The use of oligonucleotides makes it possible to expand this microchip to include the increasing number of imprinted genes discovered.
Collapse
Affiliation(s)
- A Vigé
- Inserm, AP-HP, U383, Hôpital Necker-Enfants Malades, Paris, France
| | | | | | | | | | | |
Collapse
|
13
|
Junien C, Gallou-Kabani C, Vigé A, Gross MS. [Nutritional epigenomics of metabolic syndrome]. Med Sci (Paris) 2005; 21 Spec No:44-52. [PMID: 16598905] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/08/2023] Open
Abstract
The importance of epigenetic alterations has been acknowledged in cancer for about two decades by an increasing number of molecular oncologists who contributed to deciphering the epigenetic codes and machinery and opened the road for a new generation of drugs now in clinical trials. However, the relevance of epigenetics to common diseases such as metabolic syndrome and cardiovascular disease was less conspicuous. This review focuses on converging data supporting the hypothesis that, in addition to "thrifty genotype" inheritance, individuals with metabolic syndrome (MetS)--combining disturbances in glucose and insulin metabolism, excess of predominantly abdominally distributed weight, mild dyslipidemia and hypertension, with the subsequent development of obesity, type 2 diabetes mellitus (T2D) and cardiovascular disease (CVD)--have suffered improper "epigenetic programing" during their fetal/postnatal development due to maternal inadequate nutrition and metabolic disturbances and also during their life-time. Moreover, as seen for obesity and T2D, MetS tends to appear earlier in childhood, to be more severe from generation to generation and to affect more pregnant women. Thus, in addition to maternal effects, MetS patients may display "transgenerational effects" via the incomplete erasure of epigenetic marks endured by their parents and grandparents. We highlight the susceptibility of epigenetic mechanisms controlling gene expression to environmental influences due to their inherent malleability, emphasizing the participation of transposable elements and the potential role of imprinted genes during critical time windows in epigenetic programming, from the very beginning of development throughout life. Increasing our understanding on epigenetic patterns significance and small molecules (nutrients, drugs) that reverse epigenetic (in) activation should provide us with the means to he obsolete human thrifty genotype into a "squandering" phenotype.
Collapse
Affiliation(s)
- Claudine Junien
- Inserm U.383, Génétique, chromosome et cancer, Hôpital Necker Enfants-Malades, 149, rue de Sèvres, 75743 Paris Cedex 15, France.
| | | | | | | |
Collapse
|
14
|
Abstract
Human epidemiological studies and appropriately designed dietary interventions in animal models have provided considerable evidence to suggest that maternal nutritional imbalance and metabolic disturbances, during critical time windows of development, may have a persistent effect on the health of the offspring and may even be transmitted to the next generation. We now need to explain the mechanisms involved in generating such responses. The idea that epigenetic changes associated with chromatin remodeling and regulation of gene expression underlie the developmental programming of metabolic syndrome is gaining acceptance. Epigenetic alterations have been known to be of importance in cancer for approximately 2 decades. This has made it possible to decipher epigenetic codes and machinery and has led to the development of a new generation of drugs now in clinical trials. Although less conspicuous, epigenetic alterations have also been progressively shown to be relevant to common diseases such as atherosclerosis and type 2 diabetes. Imprinted genes, with their key roles in controlling feto-placental nutrient supply and demand and their epigenetic lability in response to nutrients, may play an important role in adaptation/evolution. The combination of these various lines of research on epigenetic programming processes has highlighted new possibilities for the prevention and treatment of metabolic syndrome.
Collapse
Affiliation(s)
- Catherine Gallou-Kabani
- INSERM Unit 383, Clinique Maurice Lamy, porte 15, Hôpital Necker-Enfants Malades, 149 rue de Sèvres, 75743 Paris, France
| | | |
Collapse
|
15
|
Abstract
The importance of epigenetic alterations has been acknowledged in cancer for about two decades by an increasing number of molecular oncologists who contributed to deciphering the epigenetic codes and machinery and opened the road for a new generation of drugs now in clinical trials. However, the relevance of epigenetics to common diseases such as metabolic syndrome and cardiovascular disease was less conspicuous. This review focuses on converging data supporting the hypothesis that, in addition to "thrifty genotype" inheritance, individuals with metabolic syndrome (MetS)--combining disturbances in glucose and insulin metabolism, excess of predominantly abdominally distributed weight, mild dyslipidemia and hypertension, with the subsequent development of obesity, type 2 diabetes mellitus (T2D) and cardiovascular disease (CVD)--have suffered improper "epigenetic programming" during their fetal/postnatal development due to maternal inadequate nutrition and metabolic disturbances and also during their lifetime. Moreover, as seen for obesity and T2D, MetS tends to appear earlier in childhood, to be more severe from generation to generation and to affect more pregnant women. Thus, in addition to maternal effects, MetS patients may display "transgenerational effects" via the incomplete erasure of epigenetic marks endured by their parents and grandparents. We highlight the susceptibility of epigenetic mechanisms controlling gene expression to environmental influences due to their inherent malleability, emphasizing the participation of transposable elements and the potential role of imprinted genes during critical time windows in epigenetic programming, from the very beginning of development throughout life. Increasing our understanding on epigenetic patterns significance and small molecules (nutrients, drugs) that reverse epigenetic (in)activation should provide us with the means to "unlock" silenced (enhanced) genes, and to "convert" the obsolete human thrifty genotype into a "squandering" phenotype.
Collapse
Affiliation(s)
- Claudine Junien
- Inserm U.383, Génétique, chromosome et cancer, Hôpital Necker Enfants-Malades, 149, rue de Sèvres, 75743 Paris Cedex 15, France.
| | | | | | | |
Collapse
|
16
|
Junien C, Gallou-Kabani C, Vigé A, Gross MS. [Nutritionnal epigenomics: consequences of unbalanced diets on epigenetics processes of programming during lifespan and between generations]. Ann Endocrinol (Paris) 2005; 66:2S19-28. [PMID: 15959393] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/03/2023]
Abstract
Epigenetic changes associated with DNA methylation and histone modifications leading to chromatin remodeling and regulation of gene expression underlie the developmental programming of obesity, type 2 diabetes, cardiovascular diseases and metabolic syndrome. This review focuses on converging data supporting the hypothesis that, in addition to "thrifty genotype" inheritance, individuals with obesity, type 2 diabetes, and metabolic syndrome (MetS) with an increased risk of cardiovascular diseases have suffered improper "epigenetic programming" during their fetal/postnatal development due to maternal inadequate nutrition and metabolic disturbances and also during their lifetime, that could even be transmitted to the next generation(s). We highlight the susceptibility of epigenetic mechanisms controlling gene expression to environmental influences due to their inherent malleability, emphasizing the participation of transposable elements and the potential role of imprinted genes during critical time windows in epigenetic programming, from the very beginning of development, throughout life. Increasing our understanding on epigenetic patterns significance and their role in development, evolution and adaptation and on small molecules (nutrients, drugs) that reverse epigenetic (in)activation should provide us with the means to "unlock" silenced (enhanced) genes, and to "convert" the obsolete human thrifty genotype into a "squandering" phenotype.
Collapse
Affiliation(s)
- C Junien
- INSERM Unité de Recherche 383 Génétique, Chromosome et Cancer, Hôpital Necker-Enfants Malades, Paris, France.
| | | | | | | |
Collapse
|
17
|
Junien C, Gallou-Kabani C, Vigé A, Gross MS. Epigénomique nutritionnelle : impact de régimes alimentaires déséquilibrés sur les processus épigénétiques de programmation au cours de la vie et transgénérationnels. Annales d'Endocrinologie 2005. [DOI: 10.1016/s0003-4266(05)81742-1] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/03/2023]
|